ArticlemedRxiv : the preprint server for health sciences2025
Cell-type aware transcriptome-wide association study of mammographic density phenotypes.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
Abstract
Background: Mammographic density (MD) phenotypes are highly heritable and strongly associated with breast cancer risk. Genetic variants identified by genome-wide association studies (GWAS) explain only a small fraction of the heritability, and the responsible genes remain largely unknown. Transcriptome-wide association studies (TWAS) can improve power and identify genes associated with MD through their genetically regulated gene expression (GReX) levels. However, cell-type heterogeneity in bulk tissue samples can obscure disease associations. Here, we conduct TWAS of MD phenotypes using standard approaches and a new cell-type-aware framework. Methods: The study population included 24,158 women of European ancestry who underwent screening with Hologic (n=20,282) or GE (n=3,876) digital mammography and participated in Kaiser's Research Program on Genes Environment and Health. Dense area (DA), nondense area (NDA), and percent density (PD) were measured centrally using Cumulus6. Tissue-level gene expression was estimated using standard elastic-net models. Cell-type-specific expression in mammary epithelial, fibroblast, and adipocyte cells were estimated using MiXcan2. Linear regression was used to assess associations of GReX levels with MD phenotypes, adjusted for age at mammography, BMI, and other covariates. Statistical significance was determined by controlling the false-discovery rate at 0.05. Results: A total of 20 genes at 16 independent loci were significantly associated with MD phenotypes, including 6 novel genes at 6 independent loci not found by prior GWAS or TWAS of MD phenotypes. We discovered that one of the novel MD genes, Conclusion: This TWAS identified novel genes for MD phenotypes and breast cancer risk, and prioritized genes at known GWAS loci that are likely to be causally associated through their expression levels in mammary epithelial, fibroblast, or adipocyte cells. Disentangling the distinct effects of gene expression in different mammary cell types through cell-type-aware analysis can yield new gene discoveries and insights into the biological basis of dense vs. nondense breast tissue.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.